To asses the role of virus load in the pathogenesis of hemorrhagic fever with renal syndrome, the serum Dobrava virus RNA load in 46 patients was measured with a novel quantitative real-time reverse-transcriptase polymerase chain reacion assay and compared to the disease severity. The level of viremia, detected in 26 patients, ranged from 10 2 -10 8 copies/mL of serum. The patients with severe disease had, on average, higher viral RNA loads than patients with a milder course of disease (6.15 vs. 4.67 log 10 copies/mL; P ‫؍‬ .053). These results suggest that the Dobrava virus load might be associated with the severity of disease.
The pathogenesis of HFRS is poorly understood, and research is limited to in vitro and rare clinical studies. Endothelial cells and monocytes are thought to be the primary cell targets of the viruses, but infection does not seem to have any direct cytopathic effect on these cells. Therefore, it has been suggested that HFRS pathogenesis is mainly immune mediated [4, 5] .
Recent investigations on Sin Nombre virus infection suggest there might be an association between the viral RNA load and the disease severity. Although the study by Terajima et al. [6] was only able to correlate high viral RNA concentrations with surrogate laboratory markers for severity, such as thrombocytopenia, Xiao et al. [7] reported that an increased Sin Nombre virus load is likely to be associated with a more severe clinical outcome. In the case of Puumala virus, a recent study found that an increase in antibody response was coupled to a decrease in Puumala virus viremia [8] .
In Slovenia, Dobrava virus and Puumala virus coexist in a single region of endemicity, and the severity of HFRS caused by Puumala virus is significantly less than that of HFRS due to Dobrava virus. Furthermore, differences in the disease severity among the HFRS cases caused by Dobrava virus have been noticed [9, 10] .
In light of recent results demonstrating an association between virus load and clinical outcome in HCPS, we investigated whether the Dobrava virus RNA load has an impact on the outcome of HFRS. A novel quantitative 1-step real-time reverse-transcriptase polymerase chain reaction (RT-PCR) to detect and quantify Dobrava virus was constructed and evaluated. This study represents the first comprehensive determination of virus load relative to the clinical course of the disease in patients infected with Dobrava virus.
Subjects, materials, and methods. Acute-phase serum samples from 46 patients in whom Dobrava virus infection was diagnosed between 1990 and 2006 were analyzed in this study. Clinical data were collected retrospectively. During the course of the disease, the clinical diagnosis was confirmed serologically by an indirect immunofluorescence assay and by enzyme-linked immunoassay IgM and IgG tests, as described previously [9] .
The patients were categorized as having severe disease (i.e., the severe group) or mild-to-moderate disease (i.e., the mild-tomoderate group), on the basis of clinical and laboratory parameters used in the proposed Croatian scale for grading the disease severity in patients with HFRS [11] . Specifically, patients with severe cases were classified as having increased serum creatinine and urea levels (maximum values of at least 4 times the normal value), the need for hemodialysis, and the presence of hemorrhagic manifestations. Since the study was retrospective, informed consent from patients was not obtained. The research protocol was approved by the National Medical Ethics Committee of the Republic of Slovenia.
Total RNA was extracted from the serum samples by the use of Trizol LS Reagent (Invitrogen Life Technologies), in accordance with the manufacturer's instructions. For the real-time RT-PCR assay, SuperScript III Platinum One-Step Quantitative RT-PCR System kit (Invitrogen Life Technologies) was used. The primers and probe were designed on the basis of the alignment of M segment sequences of different human and rodent Dobrava virus strains from Slovenia. The following sequences produced by Tib Molbiol were used: forward primer DOB L1 (nucleotides at the M segment of Dobrava virus strain L33685: 1388 -1406), 5'-GGGCAGTG-TATTTATTCAG-3'; reverse primer DOB D1 (nucleotides 1571-1554), 5'-ACTTTAAGACAACCAATA-3'; wild-type probe DOB S1 (nucleotides 1475-1495), 5'-(FAM)TTCCATG-GCTGGGCAACTGCT(DABCYL)-3'; internal control probe YFP2, 5'-(ROX)ATCGTTCGTTGAGCGATTAGCAG(BBQ)-3'. The synthetic wild-type RNA transcripts to be used as quantitative calibrators were produced. Internal control and standards were prepared as described by Drosten et al. [12] .
The reaction mixture of the RT-PCR assay, which had a total volume of 25 L, contained 1 mol/L of the forward primer, 1.5 mol/L of the reverse primer, 200 nmol/L of the wild-type probe, 200 nmol/L of the internal control probe, 100 copies of the internal control, and 5 L of RNA. Other reagents in the reaction were added as instructed by the manufacturer. Thermal cycling was done in RotorGene 3000 (Corbett Research) as follows: 42°C for 40 min, 95°C for 4 min, and 45 cycles of 15 s at 95°C, 20 s at 55°C, and 30 s at 68°C. Fluorescence was acquired during the annealing step, and signals were read at 6-carboxy-fluorescein phosphoramidite and 6-carboxy-Xrhodamine wavelengths for the wild-type and internal control probes, respectively. The analysis was done by Rotor-Gene 5 software.
The standard curve for Dobrava virus quantitation was based on the use of standards, with concentrations ranging from 1.6 ϫ 10 2 -1.6 ϫ 10 6 copies per mL of sample. The samples with a very high virus concentration were prediluted and reanalyzed.
Statistical analysis was performed using R statistical software, version 2.2.1. The relationship between the variables and the clinical classification was evaluated using the 2 test, for categorical variables, and the t test, for continuous variables. Virus loads were converted to log 10 values. Linear regression was used to assess the change of virus load in time. P values of Ͻ.05 were considered statistically significant.
Results. The sensitivity of the assay was determined with a 10-fold dilution series of RNA preparations with the concentrations ranging from 1:10 Ϫ1 to 1:10 Ϫ12 . Viral RNA was detected in all dilutions, the highest of which corresponded to 1 genome copy per reaction (160 copies/mL). The specificity of the realtime RT-PCR assay was tested using 3 hantavirus isolates, namely Puumala virus, Hantaan virus, and Seoul virus, as well as Crimean-Congo hemorrhagic fever virus, another member of the Bunyaviridae family. RNA from the other isolates could not be amplified with the assay.
To establish the reproducibility of the assay, intra-assay and interassay variability was tested. Each dilution of RNA standard preparations with known concentrations was done in triplicate and repeated on 3 different days. The intra-assay and interassay variabilities were very low, with a coefficient of variation ranging from 0% to 4.3% and 0% to 6.6%, respectively, among triplicates. In both cases, the variability was noted mostly in the highest dilutions.
Forty-six patients with confirmed acute Dobrava virus infection were enrolled in the study. On the basis of their case records, 22 patients were categorized as having severe disease and 24 as having mild-to-moderate disease. The creatinine levels ranged from 347 to 1127 mol/L (mean level, 831 mol/L) in the severe group and from 89 to 1131 mol/L (mean level, 441 mol/L) in the mild-to-moderate group, and the urea levels ranged from 18.7-76.2 mmol/L (mean level, 39.5 mmol/L) in the severe group and from 5.2 to 45.0 mmol/L (mean level, 20.9 mmol/L) in the mild-to-moderate group. Acute-phase serum samples were available for all patients. All patients had detectable anti-Dobrava virus IgM antibodies at the time of admission to the hospital. Dobrava virus RNA was detected in 26 samples (56.5%), and virus load ranged from 10 2 to 10 8 copies per mL of serum and varied according to the day of illness, the severity of disease, and the results of serological analyses (table 1) .
A comparison of virus loads in the severe group with those in the mild-to-moderate group revealed no significant differences (P ϭ .230, by the t test). Although the mean number of viral RNA copies was higher in the patients with severe disease than in those with mild-to-moderate disease, the ranges of the virus concentrations in the 2 groups overlapped ( figure 1A ). If we consider only the patients in whom Dobrava virus RNA could be detected (13 patients in the severe group and 13 patients in the mild-to-moderate group), the difference between the average virus concentrations for the 2 groups was on the boundary of statistical significance (P ϭ .053, by the t test). The patients in the severe group had, on average, higher log viral RNA values (6.15 log 10 copies/mL) than patients in the mild-to-moderate group (4.67 log 10 copies/mL) (figure 1B). Our data also revealed a significant negative linear dependence of the Dobrava virus RNA load on the day of measurement in the mild-to-moderate group (P ϭ .002). No such dependence was found in patients in the severe group (P ϭ .32) ( figure 1C) .
Since all patients included in the study had detectable IgM antibodies and only 2 patients had an end point titer of Ͻ1600, only IgG antibody response was compared to virus concentration values. Dobrava virus RNA was detected in only 1 patient (9%) with a detectable IgG response, and the measured level of viremia was very low. The 2 test showed an inverse correlation between IgG antibody titers and virus concentrations (P ϭ .003).
Last, we analyzed the relationship between the antibody response and the severity of disease. Seven patients (29%) in the mild-to-moderate group had IgG titers of Ͼ100, four of whom even had an IgG titer of Ͼ800. In the severe group, there were only 18% of patients with IgG titers of Ͼ100, only 1 of whom had an IgG titer of Ͼ800. The difference between the groups, however, was not statistically significant (P ϭ .38, by the 2 test). Discussion. This is the first study describing the serum Dobrava virus RNA load relative to the severity of disease in patients with HFRS. Our findings in patients in whom Dobrava virus was detected indicate that a higher virus load at admission to the hospital might be associated with a more severe course of disease. These findings are in accordance with those from recent studies on Sin Nombre virus RNA load in patients with HCPS, which found that high levels of viremia correlated with disease severity and that the initial virus load could be used as a prognostic marker [6, 7] . In 20 patients included in the study, Dobrava virus RNA could not be detected in acute-phase serum samples regardless of the disease severity. We therefore believe that high levels of viremia alone are not responsible for a severe outcome of disease and that the host's immune mechanisms still play an important role in the pathogenesis of HFRS.
Our data also show that a significant negative linear dependence of Dobrava virus RNA load on the day of measurement existed in the group of patients with mild-to-moderate disease. No such dependence was found in the patients with severe disease. Additionally, in 4 patients in the severe group, high virus concentrations were observed even though samples were obtained on day 10, 11, or 12 of disease. In a recent study on Puumala virus viremia, a high level of viremia was detected over a prolonged period in a patient with fatal outcome of the disease [8] . To assess whether persistent viremia is an important factor in the pathogenesis of HFRS, serial samples from patients should be tested. Since our study was conducted retrospectively, this was not possible.
This study also demonstrates that IgG antibody values are inversely correlated with virus concentration. These findings are similar to those of the study by Evander et al. [8] , in which an increase in antibody response was associated with a decrease in Puumala virus viremia in patients with nephropathia epidemicas. In addition, the specific antibody response in Dobrava virus-infected patients also indicates that a strong IgG response might be associated with a milder course of disease, because high IgG titers were detected at the time of hospital admission in 4 patients (17%) in the mild-to-moderate group, compared with only 1 patient (4%) in the severe group. Although this finding is in contrast to that of Cosgriff [2] , similar findings have been reported for patients with HCPS, where a strong negative correlation between the neutralizing antibody titer and the severity of disease was observed [13] .
In conclusion, the findings of this study suggest that the Dobrava virus load might be associated with the severity of disease. Nevertheless, the severity of the disease does not seem to depend solely on the virus concentration. Host immune mechanisms are still an important factor in the pathogenesis of HFRS. 
